Abstract
Bone marrow transplantation (BMT) has been used for the treatment of increasing numbers of patients with potentially fatal malignant conditions such as: leukemia, lymphomas, solid tumors, as well as non malignant diseases such as severe aplastic anemia, inborn errors of metabolism and congenital immuno-deficiencies. This review will be restricted to the role of BMT in malignant diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Raymakers R, de Witte T, van den Ouweland F, et al. Enrichment and cryopreservation of autologous bone marrow. In: McVie JG, Dalesio O, Smith JE (eds). Autologous bone marrow transplantation. New York: Raven Press, 1984:5–8.
Van den Ouweland F, de Witte T, Geerdink P, Haanen C. Enrichment and cryopreservation of bone marrow cells for autologous reinfusion. Cryobiol 1982;19:292–8.
De Witte T, van den Ouweland F, Raymakers R, Geerdink P, Wessels J, Haanen C. Cryopreservation and reinfusion of autologous bone marrow cells enriched for clonogenic cells by discontinuous centrifugation. Neth J Med 1983;26:67–73.
Ritz J, Bast RC, Clavell LA, et al. Autologous bone marrow transplantation in CALLA-positive acute lymphoblastic leukemia after in vitro treatment with J5 monoclonal antibody and complement. Lancet 1982;i:60–3.
Hervé P, Tamyo E, Peters A. Autologous stem cell grafting in acute myeloid leukemia. Technical approach of marrow incubation in vitro with pharmacological agents. Br J Haematol 1983;53:683–90.
De Witte T, Hoogenhout J, de Pauw B, et al. Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-ver- sus-host disease in matched allogeneic marrow transplantation. Blood 1986;67:1302–8.
De Witte T, Scheltinga-Koekman E, Plas A, et al. Enrichment of myeloid clonogenic cells by isopycnic density equilibrium centrifugation in Percoll gradients and counterflow centrifugation. Stem Cells 1982;2:308–20.
Raymakers R, de Witte T, Koekman E, Wessels J, Haanen C. Enrichment of human bone marrow aspirates for light density mononuclear cells using a Haemonetics discontinuous cell separator. Vox Sang 1986;5:146–50.
Figdor C, de Witte T, Raymakers R, Haanen C, Bont W. Concentration of hematopoietic progenitor cells from human bone marrow by a new type of bone marrow cell separator. Vox Sang 1985;49:154–60.
De Witte T, Plas A, Koekman E, Preijers F, Wessels J. A simple method to obtain low density marrow cells for human marrow transplantation. Vox Sang 1987;53:221–7.
Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation. N Engl J Med 1975;292:832–43, 895-902.
Korngold R, Sprent J. Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T-cells from marrow. J Exp Med 1979; 148: 1678–82.
Waldmann H, Polliak A, Hale G, et al. Elimination of GvHD by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (Campath-1). Lancet 1984;ii:483–5.
Prentice HG, Blacklock H, Janossy G, et al. Depletion of T-lymphocytes in donor marrow prevents significant GvHD in matched allogeneic leukemic marrow transplant recipients. Lancet 1984;i:472–6.
De Witte T, Plas A, Koekman E, et al. Separation of human bone marrow by counterflow centrifugation monitored by DNA-flowcytometry. Br J Haematol 1984;58:249–58.
Schattenberg A, de Witte T, Salden M, et al. Mixed hematopoietic chimer- ism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse. Blood 1989;73: 1367–72.
Goldman JM, Gale RP, Horowitz MM, et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Ann Int Med 1988; 108:806–14.
Horowitz MM, Gale RP, Sondel PM, et al. Graft-versus-Leukemia reactions after bone marrow transplantation. Blood 1990;75:555–62.
Report from the Working Party on Leukaemia, European Group for Bone Marrow Transplantation. Allogeneic bone marrow transplantation for leukemia in Europe. Lancet 1988;i:1379–82.
Butturini A, Gale RP. Chemotherapy versus transplantation in acute leukemia. Br J Haematol 1989;72:1–8.
International Bone Marrow Transplant Registry. Transplant or chemotherapy in acute meylogenous leukemia. Lancet 1989;i:1119–22.
Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985;313: 765–71.
Ash R, Casper JT, Chitambar CR, et al. Successful allogeneic transplantation of T-cell depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 1990;322:485–93.
Hows JM, Yin JL, Marsh J, et al. Histocompatible unrelated volunteer donors compared with HLA-nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986;68:1322–28.
Preijers FWMB, de Witte T, Wessels JMC, Meyerink JPP, Haanen C, Capel P. Cytotoxic potential of anti-CD7 immunotoxin (WT1-ricin A) to purge ex-vivo malignant T-cells in bone marrow. Br J Haematol 1989;71: 195–201.
Gorin NC, Hervé P, Aegerter P, et al. Autologous bone marrow transplantation for acute leukemia in remission. Br J Haematol 1986;64:385–95.
Maraninchi D, Mascret B, Gustaut JA, et al. Repeated high dose melphalan and unpurged AMBT in 14 patients with AML. Lancet 1984;ii:1401.
Reiffers J, Gaspard MH, Maraninchi D, et al. Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukemia in first remission: A prospective controlled trial. Br J Haematol 1989;72:57–61.
Gorin NC, Aegerter P, Aurvert B, for the EBMT. Autologous bone marrow transplantation (ABMT) for acute leukemia in remission: An analysis on 1322 cases. Bone Marrow Transplant 1989;4(suppl 2):3–5.
Preijers FWBM, de Witte T, Wessels J, et al. Autologous transplantation of bone marrow purged in vitro with anti-CD-7 (WT-1-) Ricin A immunotoxin T-cell lymphoblastic leukemia and lymphoma. Blood 1989;74: 1152–8.
Goldstone AH, Gribben JG, McMillan AK, Taghipour G. The sixth report of the EBMTG registry of ABMT in lymphomas. Bone Marrow Transplant 1989;4(suppl 2):53.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
de Witte, T., Preijers, F., Schattenberg, A., Wessels, J. (1991). Bone Marrow Stem Cells: Purification and Clinical Results. In: Sibinga, C.T.S., Kater, L. (eds) Advances in haemapheresis. Developments in Hematology and Immunology, vol 25. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3904-9_14
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3904-9_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6742-0
Online ISBN: 978-1-4615-3904-9
eBook Packages: Springer Book Archive